Showing results (61-70 of 181) with videos related to
Sort By:
Pageof 19
Gastroenterologie Clinique Et Biologique|January 1, 1991
[Esophagitis in progressive systemic scleroderma. Prevalence and risk factors in forty-six patients]A Aubert, I Lazareth, M Vayssairat, et al.Presse Medicale (Paris, France : 1983)|September 24, 1994
[A new cause of familial thrombophilia: resistance to the effect of activated protein C]J Emmerich, M Alhenc-Gelas, S Gandrille, et al.Nouvelle Revue Francaise D'Hematologie|January 1, 1992
Molecular abnormalities responsible for thrombosis. Genetic aspectsM Aiach, S Gandrille, J Emmerich, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 1, 1991
Heparin cofactor II: an acute phase reactant in patients with deep vein thrombosisP Toulon, J F Vitoux, J N Fiessinger, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|November 1, 1980
[Severe ischemia of the lower limbs after ingestion of LSD]Y Juillet, M Seurot, J C Gaux, et al.La Revue De Medecine Interne|January 1, 1997
[Distal gangrene and cryoglobulinemia related to hepatitis C virus infection with presence of anticardiolipin antibodies]F Jacq, J Emmerich, E Héron, et al.Thrombosis and Haemostasis|February 28, 1986
Heparin-associated thrombocytopenia treatment with low molecular weight heparinJ F Vitoux, J F Mathieu, M Roncato, et al.British Journal of Haematology|March 1, 1988
Association of inherited dysfibrinogenaemia and protein C deficiency in two unrelated familiesS Gandrille, P Priollet, L Capron, et al.Thrombosis and Haemostasis|August 30, 1988
Antithrombin III Avranches, a new variant with defective serine-protease inhibition--comparison with antithrombin III CharlevilleM Aiach, M Roncato, G Chadeuf, et al.Stroke|March 20, 1998
Brain involvement in scleroderma: two autopsy casesE Héron, P Fornes, A Rance, et al.Pageof 19